StonvexLoading…
StonvexStonvexStonvexCore line items from APLE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $393.49M | $337.74M | $1.41B | $1.09B | $712.07M |
Operating Income | Not available | $48.01M | $257.80M | $208.21M | $135.71M |
Net Income | Not available | $27.70M | $175.36M | $145.75M | $94.87M |
EPS (Diluted) | $0.29 | $0.12 | $0.74 | $0.61 | $0.40 |
Total Assets | Not available | $4.89B | $4.90B | $4.91B | $4.93B |
Total Liabilities | Not available | $1.77B | $1.75B | $1.72B | $1.73B |
Cash & Equivalents | Not available | $7.84M | $8.52M | $50.29M | $7.90M |
Free Cash Flow OCF − CapEx | Not available | $13.08M | $282.81M | $225.57M | $116.36M |
Shares Outstanding | Not available | 236.07M | 235.64M | 236.83M | 236.99M |